Jonathan Alicea

Resolution of iron deficiency was associated with lower mortality; however, mortality risk was similar following resolution of anemia.

There may be an association between atopic dermatitis severity and diagnosis of ocular disease, such as conjunctivitis.

All patients with severe disease had abnormal ECG readings.

The oral combination therapy can also be used as acute treatment for manic or mixed episodes.

Misha Rosenbach, MD, discusses how rising temperatures and climate change, issues of public health concern, are relevant to the field of dermatology.

Jordana Hoppe, MD, discusses the burden of cystic fibrosis on infants and children.

Specialist intervention is likely not necessary for low-risk patients; and so, non-liver specialists can be reassured of G/P’s safety profile.

There was a notable association between the comorbid population and congestive heart failure exacerbations.

Social determinants can play a large role in hindering patient readiness for adult care.

CX-01 added to standard of care was well-tolerated and did not increase incidence of bleeding in patients >59 years old.

In both studies, a higher proportion of patients on upadacitinib 15 mg and 30 mg achieved EASI-75, EASI-90, and EASI-100 compared with the placebo groups.

Internet-delivered CBT may be an efficient and convenient means for addressing behaviors that exacerbate atopic dermatitis-related symptoms.

There was an association between exercise time and increased ejection fraction.

More and more individuals are becoming diagnosed with atrial fibrillation. But the research to halt this crisis is not quite there yet.

The anticoagulant did not improve clinical outcomes when compared with prophylactic anticoagulation.

There is no clear threshold for consumption leading to an AFib event.

Patients with a preserved ejection fraction saw a significant reduction in risk for cardiovascular-related adverse events and mortality.

Patients on atorvastatin experienced similar rates of adjudicated venous thromboembolism and all-cause mortality compared to placebo.

The 1-year follow-up of the REALITY trial presented at ACC undermines previously reported 30-day findings showing noninferiority to liberal transfusions.

A post-hoc analysis sought to elucidate the contradictory results between the STRENGTH and REDUCE-IT trials.

A smaller proportion of patients who used etripamil required an emergency department intervention 5 hours post-administration—compared to placebo users.

Improvements in patient symptoms, function, and quality of life were not sustained once treatment was discontinued.

Data suggests that the non-vitamin K antagonist blood thinner may be used as default treatment among post-operative patients in need of oral anticoagulation.

Patients who received 2 mg or 4 mg of baricitinib maintained vIGA-AD scores through 68 weeks of treatment.

Sickle cell patients in rural areas may actually benefit from telemedicine practices and access to satellite clinics.

While obesity is less common in pediatric sickle cell patients, BMI may impact airway resistance in this population.

Early results from the MOMENTUM study show that treated patients experienced fewer vaso-occlusive episodes and related hospital admissions.

Data from the KITE study shows that ≥50% of brolucizumab patients maintained a 12-week interval schedule through 52 weeks.

Patients who utilized virtual and in-person visits had comparable numbers of follow-ups, referrals, and outpatient surgeries.

The implant was linked to visual acuity improvements at final follow-up visit.